SH3BGRL and acute myeloid leukemia: Knockdown of SH3BGRL in MV4, ML‐1 and MOLM‐13 AML cell lines notably promotes cell proliferation and cell cycle progression, indicating the potential use of SH3BGRL as a diagnostic and prognostic marker in AML.14